[1]
M.Dina Mary, Shantaraman Kalyanaraman, Deepadevi .G, and Vasuki Muthuraman, “Immunohistochemical loss of expression of estrogen receptor beta as a significant diagnostic marker in prostatic carcinoma”, Int. J. Heal. Clin. Res., vol. 5, no. 2, pp. 881–886, Jan. 2022.